Cargando…

Aromatase 2004, Edinburgh, UK, 6-8 September 2004

Aromatase is the key enzyme involved in oestrogen biosynthesis. Oestrogens not only influence normal development and function but are also implicated in the aetiology and progression of many diseases. Over recent years rational drug design programmes have led to the development of agents that specif...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, William R, Larionov, Alexey
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1064110/
https://www.ncbi.nlm.nih.gov/pubmed/15642156
http://dx.doi.org/10.1186/bcr964
_version_ 1782123292715384832
author Miller, William R
Larionov, Alexey
author_facet Miller, William R
Larionov, Alexey
author_sort Miller, William R
collection PubMed
description Aromatase is the key enzyme involved in oestrogen biosynthesis. Oestrogens not only influence normal development and function but are also implicated in the aetiology and progression of many diseases. Over recent years rational drug design programmes have led to the development of agents that specifically and potently inhibit aromatase. The multidisciplinary international symposium Aromatase 2004 provided a forum in which basic scientists, translational researchers and practising clinicians reviewed latest results, exchanged opinions, and defined future needs for the regulation of oestrogen biosynthesis and the use of aromatase inhibitors.
format Text
id pubmed-1064110
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-10641102005-03-11 Aromatase 2004, Edinburgh, UK, 6-8 September 2004 Miller, William R Larionov, Alexey Breast Cancer Res Meeting Report Aromatase is the key enzyme involved in oestrogen biosynthesis. Oestrogens not only influence normal development and function but are also implicated in the aetiology and progression of many diseases. Over recent years rational drug design programmes have led to the development of agents that specifically and potently inhibit aromatase. The multidisciplinary international symposium Aromatase 2004 provided a forum in which basic scientists, translational researchers and practising clinicians reviewed latest results, exchanged opinions, and defined future needs for the regulation of oestrogen biosynthesis and the use of aromatase inhibitors. BioMed Central 2005 2004-11-02 /pmc/articles/PMC1064110/ /pubmed/15642156 http://dx.doi.org/10.1186/bcr964 Text en Copyright © 2004 BioMed Central Ltd
spellingShingle Meeting Report
Miller, William R
Larionov, Alexey
Aromatase 2004, Edinburgh, UK, 6-8 September 2004
title Aromatase 2004, Edinburgh, UK, 6-8 September 2004
title_full Aromatase 2004, Edinburgh, UK, 6-8 September 2004
title_fullStr Aromatase 2004, Edinburgh, UK, 6-8 September 2004
title_full_unstemmed Aromatase 2004, Edinburgh, UK, 6-8 September 2004
title_short Aromatase 2004, Edinburgh, UK, 6-8 September 2004
title_sort aromatase 2004, edinburgh, uk, 6-8 september 2004
topic Meeting Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1064110/
https://www.ncbi.nlm.nih.gov/pubmed/15642156
http://dx.doi.org/10.1186/bcr964
work_keys_str_mv AT millerwilliamr aromatase2004edinburghuk68september2004
AT larionovalexey aromatase2004edinburghuk68september2004